← Eichor
Study identifier: NCT06328062 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA

Condition: Pain Postoperative · Osteoarthritis · Total Knee Arthroplasty  ·  Sponsor: Thammasat University Hospital

PhaseNA
Planned participants80
Who can joinAll sexes, 50 Years to 85 Years
Healthy volunteersNo

About this study

The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty. The main question\[s\] it aims to answer are: • Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty. Participants will randomized to mirogabalin or pregabalin group and will take the drug for 6 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.

This description comes directly from the study's public registry record.

Talk to the study team

Yot Tanariyakul, M.D.  ·  +66863930257  ·  y.tanariyakul@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Thammasat University HospitalKhlong Luang, Changwat Pathum Thani, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06328062